Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT ZYDUS LIFESCIENCES WOCKHARDT/
ZYDUS LIFESCIENCES
 
P/E (TTM) x -12.0 19.1 - View Chart
P/BV x 0.9 2.3 38.3% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 WOCKHARDT   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    WOCKHARDT
Mar-22
ZYDUS LIFESCIENCES
Mar-22
WOCKHARDT/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs805674 119.4%   
Low Rs253331 76.5%   
Sales per share (Unadj.) Rs224.3149.1 150.4%  
Earnings per share (Unadj.) Rs-19.422.7 -85.2%  
Cash flow per share (Unadj.) Rs-2.229.7 -7.5%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs266.0166.1 160.2%  
Shares outstanding (eoy) m144.031,023.74 14.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.43.4 70.0%   
Avg P/E ratio x-27.322.1 -123.5%  
P/CF ratio (eoy) x-238.016.9 -1,406.7%  
Price / Book Value ratio x2.03.0 65.7%  
Dividend payout %011.0 0.0%   
Avg Mkt Cap Rs m76,168514,277 14.8%   
No. of employees `000NANA-   
Total wages/salary Rs m7,49021,777 34.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,300152,652 21.2%  
Other income Rs m2002,354 8.5%   
Total revenues Rs m32,500155,006 21.0%   
Gross profit Rs m1,15034,427 3.3%  
Depreciation Rs m2,4707,130 34.6%   
Interest Rs m2,9901,270 235.4%   
Profit before tax Rs m-4,11028,381 -14.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,3205,117 -25.8%   
Profit after tax Rs m-2,79023,264 -12.0%  
Gross profit margin %3.622.6 15.8%  
Effective tax rate %32.118.0 178.1%   
Net profit margin %-8.615.2 -56.7%  
BALANCE SHEET DATA
Current assets Rs m25,890122,614 21.1%   
Current liabilities Rs m32,07078,394 40.9%   
Net working cap to sales %-19.129.0 -66.0%  
Current ratio x0.81.6 51.6%  
Inventory Days Days3193 33.8%  
Debtors Days Days1080 13.0%  
Net fixed assets Rs m50,810144,382 35.2%   
Share capital Rs m7201,024 70.3%   
"Free" reserves Rs m37,590168,972 22.2%   
Net worth Rs m38,310169,996 22.5%   
Long term debt Rs m3,5503,621 98.0%   
Total assets Rs m76,700266,996 28.7%  
Interest coverage x-0.423.3 -1.6%   
Debt to equity ratio x0.10 435.0%  
Sales to assets ratio x0.40.6 73.7%   
Return on assets %0.39.2 2.8%  
Return on equity %-7.313.7 -53.2%  
Return on capital %-2.717.1 -15.7%  
Exports to sales %00-   
Imports to sales %1.914.3 13.5%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m62421,869 2.9%   
Fx inflow Rs m2,26363,065 3.6%   
Fx outflow Rs m62421,869 2.9%   
Net fx Rs m1,63841,196 4.0%   
CASH FLOW
From Operations Rs m4,13021,041 19.6%  
From Investments Rs m-2,01011,544 -17.4%  
From Financial Activity Rs m-710-8,683 8.2%  
Net Cashflow Rs m1,38023,729 5.8%  

Share Holding

Indian Promoters % 65.8 74.9 87.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 14.9 19.6%  
FIIs % 2.8 2.9 98.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 34.3 25.1 136.3%  
Shareholders   180,170 455,624 39.5%  
Pledged promoter(s) holding % 47.8 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    CIPLA    AUROBINDO PHARMA    



Today's Market

Sensex Zooms 515 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian share markets rose today tracking the rally in US stocks after softer-than-expected US inflation data stoked speculation the Federal Reserve could pivot to a shallower pace of interest-rate hikes.